SIPA1L1 antisense RNA 1 (SIPA1L1-AS1)

SIPA1L1 antisense RNA 1 (SIPA1L1-AS1) is presumed to be a long non-coding RNA (lncRNA) transcribed antisense to the SIPA1L1 (Signal Induced Proliferation Associated 1 Like 1) gene. However, the available literature and database resources focus on SIPA1L1, a protein-coding gene involved in GTPase regulation, signaling, and cytoskeletal organization[1][2][4]. There is limited to no information on SIPA1L1-AS1 specifically, including its biological function, disease association, druggability, or role as a therapeutic target. This lack of information suggests that SIPA1L1-AS1 is not a recognized or established therapeutic target, and the entry may potentially refer to a transcript with uncertain or uncharacterized function in current scientific references.\n\n**Key justifications for entries:**\n- The term **SIPA1L1 antisense RNA 1 (SIPA1L1-AS1)** aligns with lncRNA naming conventions but is not referenced as a protein or conventional drug target in any of the major genomic or pharmacological databases or scientific articles.\n- Most available sources describe SIPA1L1 itself, a Rap GTPase-activating protein, not the antisense RNA transcript[1][2][4].\n- No evidence of **drugs, biomarkers, or disease roles** is available for SIPA1L1-AS1.\n- This entity is likely **misattributed as a receptor or molecule suitable for direct therapeutic targeting** in the commonly understood sense.\n\nIf you require information about SIPA1L1 (the protein-coding gene) instead, please clarify; otherwise, SIPA1L1-AS1 should be considered a low-evidence, likely non-target entity with no current therapeutic relevance.

Other names

SIPA1L1-AS1